2-Oxo-1,2,4,5,6,6a,7,8-octahydropyrrolo<1.2-c>pyrimidin | 91981-81-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡咯并嘧啶类
• 英文名称: 2-Oxo-1,2,4,5,6,6a,7,8-octahydropyrrolo<1.2-c>pyrimidin
• 英文别名: hexahydro-pyrrolo[1,2-c]pyrimidin-1-one；hexahydropyrrolo[1,2-c]pyrimidine-1-(12H)-one；1,3-Diaza-bicyclo[4.3.0]nonan-2-one；3,4,4a,5,6,7-hexahydro-2H-pyrrolo[1,2-c]pyrimidin-1-one
• CAS: 91981-81-6
• 化学式: C₇H₁₂N₂O
• mdl: MFCD19219201
• 分子量: 140.185
• InChiKey: FYPGLGULKXSBIE-UHFFFAOYSA-N

物化性质

• 沸点：
  342.8±9.0 °C(Predicted)
• 密度：
  1.17±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.2
• 重原子数：
  10
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.857
• 拓扑面积：
  32.3
• 氢给体数：
  1
• 氢受体数：
  1

文献信息

• Method for improved chemical synthesis of guanidinium alkaloids
  申请人：Overman E. Larry

  公开号：US20050239804A1

  公开（公告）日：2005-10-27

  Improved methods for convergent, total enantioselective synthesis of guanidinium alkaloid compounds including ones having cis- or -trans-1-oxo-and 1-iminohexahydropyrrolo [1,2c]pyrimidine units including, 13,14,15-isocrambescidin 800, crambescidin 800 and ptilomycalin A, for use as therapeutic agents having antifungal and/or antiviral and/or antitumor activity are provided. Methods for preparing novel pentacyclic intermediates for the preparation of the crambescidin/ptilomycalin family of guanidinium alkaloids and congeners are also disclosed.

  提供了改进的方法，用于收敛、完全对映选择性合成葫芦啶生物碱化合物，包括具有顺式或反式1-氧基和1-亚氨基六氢吡咯并[1,2c]嘧啶单元的化合物，包括13,14,15-异克林贝斯酸800、克林贝斯酸800和莫纳霉素A，用作具有抗真菌和/或抗病毒和/或抗肿瘤活性的治疗剂。还公开了制备新的五环中间体的方法，用于制备克林贝斯酸/莫纳霉素家族的葫芦啶生物碱及其同系物。
• HEXAHYDROPYRROLO[1,2-C]PYRIMIDINES AS ANTIVIRAL, ANTIFUNGAL AND/OR ANTITUMOR AGENTS
  申请人：THE REGENTS OF THE UNIVERSITY OF CALIFORNIA

  公开号：EP1204666A1

  公开（公告）日：2002-05-15
• [EN] HEXAHYDROPYRROLO[1,2-C]PYRIMIDINES AS ANTIVIRAL, ANTIFUNGAL AND/OR ANTITUMOR AGENTS<br/>[FR] HEXAHYDROPYRROLO[1,2-C]PYRIMIDINES UTILISEES EN TANT QU'AGENTS ANTIVIRAUX, ANTIFONGIQUES ET/OU ANTITUMORAUX
  申请人：UNIV CALIFORNIA

  公开号：WO2001000626A1

  公开（公告）日：2001-01-04

  Improved methods for convergent, total enantioselective synthesis of guanidinium alkaloid compounds including ones having cis- or -trans-1-oxo- and 1-iminohexahydropyrrolo[1,2-c]pyrimidine units including, 13,14,15-isocrambescidin 800, crambescidin 800 and ptilomycalin A, for use as therapeutic agents having antifungal and/or antiviral and/or antitumor activity are provided. Methods for preparing novel pentacyclic intermediates for the preparation of the crambescidin/ptilomycalin family of guanidinium alkaloids and congeners are also disclosed.